Claris Lifesciences has informed that the Buy Back Committee (constituted by the Board of Directors of the Company at its meeting held on January 07, 2014), at its meeting held on March 20, 2014, has approved April 02, 2014 as the record date for the purpose of determining the entitlement and the names of the equity shareholders, to whom the Letter of Offer and Tender Form will be sent and who are eligible to participate in the Buy Back up to 92,50,000 equity shares of face value of Rs 10 each at a price of Rs 250 per Equity Share payable in cash for an aggregate amount of Rs 231,25,00,000 from the equity shareholders/ beneficial owners of the Equity Shares of the Company as on the record date i.e. April 02, 2014.
The above information is a part of company’s filings submitted to BSE.
